- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Crescent Moore on Implementing Care Coordination Programs in Medicare
Crescent Moore, PharmD, PhD, BCPS, senior consultant, BluePeak Advisors, discusses how CMS is planning on implementing care coordination programs in Medicare.
Crescent Moore, PharmD, PhD, BCPS, senior consultant, BluePeak Advisors, discusses how CMS is planning on implementing care coordination programs in Medicare.
Transcript
How is CMS planning to implement care coordination programs in Medicare?
This is another situation where we’re not given a ton of guidance in terms of necessarily if CMS has an exact way of how they want those care coordination programs to be administered. We have the requirements in terms of needing to address medication adherence and really looking at a medication review and really being able to describe to the member what drugs are impacted by the Part B step therapy. I think plans are going to have to look at what makes sense for them. I’ve talked to some plans, and they have really thought more about expanding their current case management programs. So, rolling those members who would be a part of that Part B step program into their case management programs to address this.
Another program that’s already established in the Part D side that could be expanded as well is the Medication Therapy Management program, which really does already address many aspects that CMS is expecting to see in the care coordination programs.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
Bias Reduction, Better Access Key to COVID-19 Equity Gains
April 14th 2025Interventions that target enhancing health care equity among communities disproportionately affected by the COVID-19 pandemic can be improved by including comprehensive needs assessments at the patient, provider, and health system levels.
Read More
